Form 10 Explorer
10-Q
Quarterly Report
BIOMERICA, INC.

BMRA

NASDAQ

CIK: 73290

File #: 001-37863

Period End: Feb 29, 2024

Fiscal Year: 2024

View on EDGAR
Balance Sheet
35 line items · 2 periods
XBRL
ItemFeb 29, 2024May 31, 2023
Assets
Current Assets:
Cash and Cash Equivalents
5,319,0009,719,000
Accounts Receivable
1,130,000722,000
Inventory
2,129,0002,056,000
Other Non-Operating Current Assets
268,000300,000
Total current assets
8,846,00012,797,000
Property, Plant and Equipment
194,000213,000
MEXICO
15,00017,000
Operating Lease Right-of-Use Asset
817,0001,035,000
Cash and Cash Equivalents
165,000165,000
Polish Distributor
165,000—
Intangible Assets
216,000165,000
Other Non-Operating Non-Current Assets
104,00079,000
Total Assets
10,342,00014,454,000
Liabilities and Shareholders’ Equity
Current Liabilities:
Accounts Payable
885,000892,000
Other Current Liabilities
702,000696,000
Other Current Liabilities
85,00060,000
Operating Lease Liability, Current
319,000297,000
Total current liabilities
1,991,0001,945,000
Operating Lease Liability, Non-Current
543,000785,000
Total Liabilities
2,534,0002,730,000
Shareholders’ Equity:
Total Stockholders' Equity
1,346,0001,346,000
Total Stockholders' Equity
53,338,00052,705,000
Total Stockholders' Equity
(102,000)(110,000)
Total Stockholders' Equity
(46,774,000)(42,217,000)
Total Shareholders’ Equity
7,808,00011,724,000
Common Stock
1,346,0001,346,000
Additional Paid-in Capital
53,338,00052,705,000
AOCI Attributable to Parent
(102,000)(110,000)
Retained Earnings
(46,774,000)(42,217,000)
Total Liabilities and Shareholders’ Equity
10,342,00014,454,000